Prevention of Recurrence in Depression With Drugs and CT
Completed · Phase 4
Conditions studied: Depression
In brief
This study will determine whether the addition of Cognitive Therapy (CT) to antidepressant medication (ADM) enhances treatment for depression. This study will also test whether the addition of CT to ADM will prevent recurrences of depression after therapy is over.
Key facts
- Study ID
- NCT00057577
- Run by
- Vanderbilt University
- People needed
- 452
- Starts
- 2002-10-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2017-05-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Recurrent or chronic major depressive disorder
You may not qualify if…
- Current diagnosis of psychotic affective disorder
- History of nonaffective psychotic disorder
- Substance dependence last three months requiring detox
- Schizotypal, antisocial, or borderline personality disorder
Where it is running
- Rush Medical Center - Treatment Research Unit — Chicago, Illinois, United States
- Depression Research Unit, University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Vanderbilt Adult Outpatient Psychiatry — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.